TWST Stock Hits Multi-Year High, But ‘Pharma Bro’ Martin Shkreli Calls Twist A Short
Twist traded as high as $163.70 on Thursday and finished the session about 9% higher near $156. The stock’s bounce on Thursday followed a pact with Eli Lilly’s Tunelab and a price target hike from Leerink. Twist sells custom-made DNA to research labs and drugmakers, including genes, DNA fragments, testing kits, and antibody-discovery work. Last … Read more